Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-27T02:57:51.771Z Has data issue: false hasContentIssue false
  • English
  • Français

Differential illness intrusiveness associated with sleep-promoting medications

Published online by Cambridge University Press:  16 April 2020

GM Devins ,
M Flanigan ,
JAE Fleming ,
R Morehouse ,
A Moscovitch ,
J Plamondon ,
L Reinish  and
CM Shapiro
GM Devins
Affiliation:
Culture, Community, and Health Studies, Clarke Institute of Psychiatry, 250 College Street, Toronto, OntarioM5T 1R8, Canada University of Toronto, Canada The Toronto Hospital, Canada
M Flanigan
Affiliation:
The Toronto Hospital, Canada
JAE Fleming
Affiliation:
University of British Columbia, Canada
R Morehouse
Affiliation:
Dalhousie University, Canada
A Moscovitch
Affiliation:
University of Calgary, Canada
J Plamondon
Affiliation:
Laval University, Canada
L Reinish
Affiliation:
The Toronto Hospital, Canada
CM Shapiro
Affiliation:
University of Toronto, Canada
Get access

Summary

Differences in daytime sleepiness, lifestyle disruptions, and emotional distress were compared across nine groups taking sleep-promoting substances. Groups included individuals taking zopiclone (n = 274), amitriptyline (n = 107), lorazepam (n = 258), oxazepam (n= 141), diphenhydramine HCl (n = 99), triazolam(n = 137), long acting benzodiazepines (n = 120), temazepam (n = 176), and miscellaneous other medications (n = 286). Data were gathered by self-report, using standardized instruments in a mail-back questionnaire procedure. Respondents included the first 1,598 participants enrolled in a Canadian multicentre project, including six sites attached to academic psychiatric units. Results indicated that quality of life effects differed across groups in both daytime sleepiness and lifestyle disruptions (illness intrusiveness), but not in depressive symptoms. Daytime sleepiness was significantly higher among people taking diphenhydramine HCl as compared to temazepam, zopiclone, lorazepam, and oxazepam. Illness intrusiveness was significantly higher among patients taking amitriptyline as compared to those taking triazolam, oxazepam, long-acting benzodiazepines, and zopiclone. It may be useful to inform patients of differences in psychosocial outcomes when prescribing hypnotic medications.

Keywords

sleepquality of lifeillness intrusivenesspharmacotherapyhypnotic medications
Type
Research Article
Information
European Psychiatry , Volume 10 , Issue S3: Satellite Symposium to the AEP Congress , 1995 , pp. 153s - 159s
Copyright
Copyright © Elsevier, Paris 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Binik, YMDevins, GMOrme, CMPsychological stress and coping in end-stage renal disease. In: Neufeld, RWJ ed. Advances in the investigation of psychological stress New York: Wiley, 1989 305–42Google Scholar
Binik, YMChowanec, GDQuality of life. In: Garovoy, MRGuttmann, RD ed. Renal Transplantation New York: Churchill Livingstone, 1986 341–53Google Scholar
Binik, YMChowanec, GDDevins, GMMarital role strain, illness intrusiveness, and their impact on marital and individual adjustment in end-stage renal disease. Psychol Health 1990;4:245–57CrossRefGoogle Scholar
Broughton, RJShapiro, CMParasomnias (vol 8 of 10).Sleep solutions St Laurent, Quebec: Komunicom Publications, 1992Google Scholar
Croog, SHLevine, STesta, MA, et al. The effects of antihyper-tensive therapy on the quality of life. N Engl J Med 1986;314:1657–64CrossRefGoogle Scholar
Currie, DJChoosing the right hypnotic: pharmacotherapy of sleep disturbance. In: Kumar, VMMallick, HNNayar, U ed. Sleep-wakefulness New Delhi: Wiley Eastern, 1993 133–7Google Scholar
Derogatis, LRThe SCL-90-R administration, scoring, and procedures manual I Baltimore: Clinical Psychometric Research, 1977Google Scholar
Devins, GMEnhancing personal control and minimizing illness intrusiveness. In: Kutner, NGCardenas, DDBower, JD ed. Maximizing rehabilitation in chronic renal disease New York: PMA, 1989 109–36Google Scholar
Devins, GMIllness intrusiveness and the psychosocial impact of end-stage renal disease. In: Hardy, MAKiernan, JKutscher, AHCahill, LBevenitsky, AI ed. Psychosocial aspects of end-stage renal disease: issues of our times New York: Haworth Press, 1991 83–102Google Scholar
Devins, GMPsychosocial impact of illness from a developmental-systems perspective: New directions for health psychology. Can J Behav Sci 1993;25:329–31CrossRefGoogle Scholar
Devins, GMPsychosocial issues in end-stage renal disease. Adv Renal Repl Ther 1994;1:195–7CrossRefGoogle ScholarPubMed
Devins, GMIllness intrusiveness and the psychosocial impact of lifestyle disruptions in chronic life-threatening disease. Adv Renal Repl Ther 1994;1:251–63CrossRefGoogle ScholarPubMed
Devins, GMBinik, YMHutchinson, TAHollomby, DJBarre, PEGuttmann, RDThe emotional impact of end-stage renal disease: importance of patients'perceptions of intrusiveness and control. Int J Psychiat Med 1983;13:327–43CrossRefGoogle Scholar
Devins, GMEdworthy, SMGuthrie, NGMartin, LIllness intrusiveness in rheumatoid arthritis: differential impact on depressive symptoms over the adult lifespan. J Rheumatol 1992;19:709–15Google ScholarPubMed
Devins, GMEdworthy, SMPaul, LC, et al. Restless sleep, illness intrusiveness, and depressive symptoms in three chronic illness conditions: rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. J Psychosom Res 1993;37:163–70Google ScholarPubMed
Devins, GMEdworthy, SMSeland, TPKlein, GMPaul, LCMandin, HDifferences in illness intrusiveness across rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. J Nerv Ment Dis 1993;181:377–81CrossRefGoogle ScholarPubMed
Devins, GMMandin, HHons, RB, et al. Illness intrusiveness and quality of life in end-stage renal disease: comparison and stabilitym across treatment modalities. Health Psychol 1990;9:117–42CrossRefGoogle ScholarPubMed
Devins, GMOrme, CMCenter for epidemiologic studies depression scale. In: Keyser, DJSweetland, RC ed. Test Critiques 2nd ed. Kansas: Test Corporation of America, 1985 144–60Google Scholar
Devins, GMOrme, CMCostello, CG, et al. Measuring depressive symptoms in illness populations: psychometric properties of the Center for Epidemiologic Studies Depression (CES-D) scale. Psychol Health 1988;2:139–56Google Scholar
Devins, GMSeland, TPEmotional impact of multiple sclerosis: recent findings and suggestions for future research. Psychol Bull 1987;101:363–75Google ScholarPubMed
Devins, GMSeland, TPKlein, GMEdworthy, SMSaary, MJStability and determinants of psychosocial well being in multiple sclerosis. Rehabil Psychol 1993;38:11–26CrossRefGoogle Scholar
Devins, GMStam, HJKoopmans, JPPsychosocial impact of laryn-gectomy mediated by perceived stigma and illness intrusiveness. Can J Psychiat 1994;39:608–16CrossRefGoogle ScholarPubMed
Evans, RWManninen, DLGarrison, LP, et al. The quality of life of patients with end-stage renal disease. N Engl J Med 1985;312:553–9CrossRefGoogle ScholarPubMed
Flemming, JAEShapiro, CMSleep solutions.Insomnia management vol 2 of 10 St.-Laurent, Quebec: Komunicom Publications, 1992Google Scholar
Ford, DEKamerow, DBEpidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention?. JAMA 1989;262:1479–84CrossRefGoogle ScholarPubMed
Johns, MWA new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;4:540–5CrossRefGoogle Scholar
Kales, AKales, JD ed. Evaluation and treatment of insomnia New York: Oxford University Press, 1984Google Scholar
Kasper, SWehr, TABartko, JJGaist, PARosenthal, NEEpidemiological findings of seasonal changes in mood and behavior: a telephone survey of Montgomery County, Maryland. Arch Gen Psychiatry 1989;46:823–33Google ScholarPubMed
Najman, JMLevine, SEvaluating the impact of medical care and technologies on the quality of life: a review and critique. Soc Sci Med 1981;15:107–15Google ScholarPubMed
Radloff, LSThe CES-D scale: a self-report depression scale for research in the general population. App Psychol Meas 1977;3:385–401CrossRefGoogle Scholar
Rodin, GMVoshart, KDepressive symptoms and functional impairment in the medically ill. Gen Hosp Psychiatry 1987;9:251–8CrossRefGoogle ScholarPubMed
Schuessler, KFFisher, GAQuality of life research and sociology. Ann Rev Social 1985;11:129–49CrossRefGoogle Scholar
Shapiro, CMMacFarlane, JGHussain, MG ed. Conquering insomnia Hamilton: Ont. Empowering Press, 1994Google Scholar
Shapiro, CMSandor, PSleep patterns in depression and anxiety: theory and pharmacological effects. J Psychosom Res 1994; 38: 125–40Google Scholar
Troidl, HKusche, JVestweber, KEypasch, EKoeppen, LBouillon, BQuality of life: an important endpoint both in surgical practice and research. J Chron Dix 4061987 523–8CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.